Hoth Therapeutics Joins NVIDIA Connect Program to Expand AI and Accelerated Computing Capabilities

Hoth Therapeutics, a clinical-stage biopharmaceutical company, has been accepted into the NVIDIA Connect Program, providing the company with access to NVIDIA’s accelerated computing and AI development resources. Hoth plans to use these tools to speed computational modeling, data processing, and target evaluation across its early-stage pipeline, which includes programs in dermatology, inflammation, and oncology. The company said the program will support both internal research and collaborations by enabling larger-scale simulations and AI-driven analysis. The connection provides Hoth Therapeutics with GPU-accelerated developer tools, SDKs and APIs as well as co-marketing for increased visibility.

The move reflects broader adoption of high-performance computing in biotech, where AI-assisted drug discovery is rapidly becoming standard. For smaller developers like Hoth, access to NVIDIA tooling through an accelerator program offers a cost-effective way to modernize computational workflows without building extensive in-house hardware capacity.

Posted by MedCloudInsider Editors on 11/24/2025